Nautilus Biotechnology, Inc. (NAUT) Tops Q3 EPS by 8c
Tweet
Share
E-mailGet Alerts NAUT Hot Sheet
Join SI Premium – FREE
Nautilus Biotechnology, Inc. (NASDAQ: NAUT) reported Q3 EPS of ($0.11), $0.08 better than the analyst estimate of ($0.19).
For earnings history and earnings-related data on Nautilus Biotechnology, Inc. (NAUT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
